Agriculture Roundup for Friday July 17, 2020
Elanco Animal Health has agreed to make changes to a $7.6 billion deal to buy several health care products for animals from Bayer AG in order to get approval from a Canadian regulator.
The Competition Bureau said it concluded that Bayer and Elanco are each other’s biggest competitors in several Canadian markets.
Bayer will keep the Canadian distribution rights to several poultry insecticides that Elanco was going to acquire under the deal.
Elanco agreed to divest one of its prescription medications for treating dogs and one of Bayer’s medications for treating cats after the deal closes.